This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
1 Oct 2010

Cyprotex Officially Open New Toxicology Laboratory

David Rutley, MP for Macclesfield, has officially open Cyprotex's new toxicology facility at its headquarters in Macclesfield, UK.

David Rutley, MP for Macclesfield, has officially open Cyprotex’s new toxicology facility at its headquarters in Macclesfield, UK.

The additional 90 square metres of laboratory space houses the very latest technology in multi-parametric automated fluorescent imaging and cellular analysis, a Thermo Scientific Cellomics ArrayScan® VTI High Content Screening Reader. This technology is considered to be a breakthrough in terms of in vitro toxicity testing as multiple markers of toxicity can be analysed in a single cell which improves sensitivity and prediction of toxic effect. It has been extensively validated, and is now being adopted throughout the pharmaceutical industry. 

Cyprotex’s expansion into the toxicology market has been enhanced by its recent acquisition of US-based Apredica and Cellumen’s novel CellCiphr informatics platform and assets. As well as an additional four Cellomics High Content Screening instruments in the US, Cyprot

Related News